Klebsiella pneumoniae LO10 producing extended-spectrum beta-lactamase SHV-12 in Saudi Arabia

Journal of Chemotherapy

Volumn 20, Issue 6, 2008, Pages 709-713

  Al Obein, Suleiman ^a   Bremont, S ^b   Jabri, L ^a   Massoudi, N ^a   Haddad, Q ^a  

^a SECURITY FORCES HOSPITAL   (Saudi Arabia)

^b INSTITUT PASTEUR   (France)

Author keywords

Bacteremia; Cephalosporin resistance; ESBL; Klebsielle pneumoniae; Saudi Arabia; Transconjugants

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; BETA LACTAMASE SHV 12; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLOXACILLIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; MEROPENEM; OXACILLIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TICARCILLIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BACTERIUM CONJUGATION; BACTERIUM TRANSFORMATION; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; DRUG EXPOSURE; ENZYME SYNTHESIS; EPIDEMIC; ESCHERICHIA COLI; GENE SEQUENCE; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION CONTROL; KLEBSIELLA PNEUMONIAE; LENGTH OF STAY; MINIMUM INHIBITORY CONCENTRATION; NEWBORN; NEWBORN SEPSIS; NONHUMAN; PLASMID; SAUDI ARABIA;

EID: 59349103239     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2008.20.6.709     Document Type: Article

References (21)

1. Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 1998; 11:589-603.
2. Yinnon A M, Butnaru A, Raveh D, Jerassy Z, Rudensky B. Klebsiella bacteremia: community versus nosocomial infection. QJM 1996; 89:933-941.
3. Hable KA, Matsen JM, Wheeler DJ, Hunt CE, Quie PG. Klebsietla type 33 septicemia in an infant intensive care unit. J Pediatr 1972; 80:920-924.
4. Hobson RP, MacKenzie FM, Gould IM. An outbreak of multiply-resistant Klebsiella pneumoniae in the Grampian region of Scotland. J Hosp Infect 1996; 33:249-262.
5. Margreet GF, Inge CG, Irma MK, Patty JER, Alewijn O, Arnold GV, et al. Colonization and resistance dynamics of gram-negative bacteria in patients during and after hospitalization. Antimicrob Agents Chemother 2005; 49(7): 2879-2886.
6. Bradford PA, Urban C, Mariano N, Projan SJ, Rahal JJ, Bush K. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the loss of an outer membrane protein. Antimicrob Agents Chemother 1997; 41:563-569.
7. Nuesch-Inderbinen MT, Kayser FH, Hachler H. Survey and molecular genetics of SHV β-lactamases in Enterobacteriaceae in Switzerland: two novel enzymes, SHV-11 and SHV-12. Antimicrob Agents Chemother. 1997; 41:943-949.
8. Kim J, Kwon Y, Pai H, Kim JW, Cho DT. Survey of Klebsiella pneumoniae strains producing extended-spectrum β-lactamases: prevalence of SHV-12 and SHV-2a in Korea. J Clin Microbiol 1998; 36:1446-1449.
9. Yan JJ, Wu SM, Tsai SH, Wu JJ, Su IJM. Prevalence of SHV-12 among clinical isolates of Klebsiella pneumoniae producing extended-spectrum β-lactamases and identification of a novel AmpC enzyme (CMY-8) in Southern Taiwan. Antimicrob Agents Chemother 2000; 44:1438-1442
10. Cobo J, Morosini MI, Pintado V, Tato M, Samaranch N, Baquero F, Canton R. Use of tigecycline for the treatment of prolonged bacteremia due to a multiresistant VIM-1 and SHV-12 beta-lactamase-producing Klebsiella pneumoniae epidemic clone. Diagn Microbiol Infect Dis 2008;60(3):319-22
11. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa. 1997.
12. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests, 6th ed. Approved standard M2-A6 (M100-S7). National Committee for Clinical Laboratory Standards, Wayne, Pa. 1997.
13. Gaillot O, Maruéjouls C, Abachin E, Lecuru F, Arlet G, Simonet M, Berche P. Nosocomial outbreak of Klebsiella pneumoniae producing shv-5 extended-spectrum β-lactamse originating from a contaminated ultrasonography, coupling gel. J Clin Microbiol 1998;36 (5) 1357-1360.
14. Trieu-Cuot P, Courvalin P. Transposition behavior of IS15 and its progenitor IS15-delta:are cointegrates exclusive end products? Plasmid 1985;14(1):80-89.
15. Sambrook J, Russell D. Molecular cloning: a laboratory manual, 3rd ed. 2001; Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N. Y.
16. Mabilat C, Goussard S. PCR detection and identification of genes for extended-spectrum β-lactamases. In Persing DH, Smith TF, Tenover FC, White TJ (ed.), Diagnostic molecular microbiology: principles and applications. American Society for Microbiology, Washington, D.C. 1993; 553-559.
17. Goldmann DA, Leclair J, Macone A. Bacterial colonization of neonates admitted to an intensive care environment. J Pediatr 1978; 93:288-293.
18. Pena C, Pujol M, Ardanuy C, et al. Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended spectrum beta-lactamases: Are we losing the battle? Aust J Med Sci 1995; 16:16-25.
19. Nathisuwan S, Burgess DS, Lewis JS. Extended spectrum beta-lactamases: epidemiology, detection and treatment. Pharmacotherapy 2001; 21:920-928.
20. Davies J. Inactivation of antibiotics and the dissemination of resistance genes. Science 1994; 264:375.
21. Coulter C, Faoagali JC, Doige S, Bodman J, George N. Hand culture surveillance to investigate transmission of epidemic extended-spectrum beta-lactamase producing Klebsiella pneumoniae in a major intensive care unit. Aust NZ J Med 1995;25:572. (abstract).